Evolution of research funding for neglected tropical diseases in Brazil, 2004-2020.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
03 2023
Historique:
received: 05 09 2022
accepted: 01 02 2023
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 22 3 2023
Statut: epublish

Résumé

Neglected tropical diseases are a global public health problem. Although Brazil is largely responsible for their occurrence in Latin America, research funding on the subject does not meet the population's health needs. The present study analyzed the evolution of research funding for neglected tropical diseases by the Ministry of Health and its partners in Brazil, from 2004 to 2020. This is a retrospective study of data from investigations registered on Health Research (Pesquisa Saúde in Portuguese), a public repository for research funded by the Ministry of Health's Department of Science and Technology. The temporal trend of funding and the influence of federal government changes on funding were analyzed using Prais-Winster generalized linear regression. From 2004 to 2020, 1,158 studies were financed (purchasing power parity (PPP$) 230.9 million), with most funding aimed at biomedical research (81.6%) and topics involving dengue, leishmaniasis and tuberculosis (60.2%). Funding was stationary (annual percent change of -5.7%; 95%CI -54.0 to 45.0) and influenced by changes to the federal government. Research funding was lacking for chikungunya, Chagas disease, schistosomiasis, malaria and taeniasis/cysticercosis, diseases with a high prevalence, burden or mortality rates in Brazil. Although the Ministry of Health had several budgetary partners, it was the main funder, with 69.8% of investments. The study revealed that research funding for neglected tropical diseases has stagnated over the years and that diseases with a high prevalence, burden and mortality rate receive little funding. These findings demonstrate the need to strengthen the health research system by providing sustainable funding for research on neglected tropical diseases that is consistent with the population's health needs.

Identifiants

pubmed: 36928796
doi: 10.1371/journal.pntd.0011134
pii: PNTD-D-22-01150
pmc: PMC10019684
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0011134

Informations de copyright

Copyright: © 2023 Melo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests:the author G.B.T.M. hold technical position at Ministry of Health of Brazil. The authors A.A.T., E.N.S., L.Y.T.U. and M.T.O. held techinical positions at Ministry of Health of Brazil in differents periods.

Références

Trans R Soc Trop Med Hyg. 2021 Jan 28;115(2):182-184
pubmed: 33169163
BMC Health Serv Res. 2019 Apr 24;19(1):248
pubmed: 31018843
PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009099
pubmed: 33657097
Trop Med Int Health. 2020 Nov;25(11):1373-1384
pubmed: 32860446
Rev Assoc Med Bras (1992). 2018 Mar;64(3):281-289
pubmed: 29641786
Clin Exp Dermatol. 2022 Mar;47(3):516-521
pubmed: 34480806
Front Microbiol. 2021 Jul 29;12:711107
pubmed: 34394061
PLoS Negl Trop Dis. 2018 Jun 4;12(6):e0006559
pubmed: 29864133
Lancet Infect Dis. 2017 Mar;17(3):e88-e100
pubmed: 28185868
Infect Dis Poverty. 2020 Jan 28;9(1):10
pubmed: 31987053
BMC Med. 2015 Apr 30;13:102
pubmed: 25976325
PLoS Negl Trop Dis. 2020 Aug 12;14(8):e0008498
pubmed: 32785262
Public Health Res Pract. 2021 Nov 10;31(4):
pubmed: 34753166
Glob Health Action. 2013 Oct 10;6:22450
pubmed: 24119660
Health Res Policy Syst. 2016 Nov 8;14(1):80
pubmed: 27825383
Clin Infect Dis. 2018 Jul 18;67(3):323-326
pubmed: 29688342
Int Health. 2019 Sep 2;11(5):338-340
pubmed: 31529110
Lancet Infect Dis. 2019 Feb;19(2):125-127
pubmed: 30712832
Cien Saude Colet. 2017 May;22(5):1441-1454
pubmed: 28538916
Gates Open Res. 2018 Apr 26;2:23
pubmed: 30234193
Trans R Soc Trop Med Hyg. 2021 Jan 28;115(2):179-181
pubmed: 33427289
Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):2-6
pubmed: 29513837
PLoS Negl Trop Dis. 2010 Jan 19;4(1):e584
pubmed: 20098726
Health Res Policy Syst. 2016 Oct 10;14(1):76
pubmed: 27724907
Trans R Soc Trop Med Hyg. 2021 Jan 28;115(2):185-187
pubmed: 33508098
Clin Infect Dis. 2021 Jun 14;72(Suppl 3):S210-S216
pubmed: 33977302
BMJ. 2018 Mar 20;360:k1182
pubmed: 29559440

Auteurs

Gabriela Bardelini Tavares Melo (GBT)

Graduate Program in Health Sciences and Technologies, Faculty of Ceilândia - University of Brasilia, Federal District, Brasilia, Brazil.
Department of Science and Technology, Ministry of Health, Federal District, Brasilia, Brazil.

Antonia Angulo-Tuesta (A)

Graduate Program in Health Sciences and Technologies, Faculty of Ceilândia - University of Brasilia, Federal District, Brasilia, Brazil.

Everton Nunes da Silva (END)

Graduate Program in Health Sciences and Technologies, Faculty of Ceilândia - University of Brasilia, Federal District, Brasilia, Brazil.

Thaís da Silva Santos (TDS)

Graduate Program in Health Sciences and Technologies, Faculty of Ceilândia - University of Brasilia, Federal District, Brasilia, Brazil.

Liza Yurie Teruya Uchimura (LYT)

Hospital do Coração, São Paulo State, São Paulo, Brazil.

Marcos Takashi Obara (MT)

Graduate Program in Health Sciences and Technologies, Faculty of Ceilândia - University of Brasilia, Federal District, Brasilia, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH